The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure

With the development of regenerative medicine, a variety of mesenchymal stem cells (MSCs) are increasingly considered for the treatment of premature ovarian failure (POF). Reportedly, bone marrow-derived MSCs (BMSCs) improve the ovarian reserve, which mainly depends on homing and paracrine activitie...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yantao, Chen, Dongmei, Yang, Lingling, Hou, Qiaoni, Ma, Huiming, Xu, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172726/
https://www.ncbi.nlm.nih.gov/pubmed/30286808
http://dx.doi.org/10.1186/s13287-018-1008-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172726/
https://www.ncbi.nlm.nih.gov/pubmed/30286808
http://dx.doi.org/10.1186/s13287-018-1008-9

Ejemplares similares